Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy - Thang, SP; Violet, J; Sandhu, S (Eur Urol Oncol, 2019)
et al.